These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 34558234)

  • 41. Surviving as a Community: Antibiotic Tolerance and Persistence in Bacterial Biofilms.
    Yan J; Bassler BL
    Cell Host Microbe; 2019 Jul; 26(1):15-21. PubMed ID: 31295420
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanisms and Control Strategies of Antibiotic Resistance in Pathological Biofilms.
    Luo Y; Yang Q; Zhang D; Yan W
    J Microbiol Biotechnol; 2021 Jan; 31(1):1-7. PubMed ID: 33323672
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Insights into antibiotic resistance through metagenomic approaches.
    Schmieder R; Edwards R
    Future Microbiol; 2012 Jan; 7(1):73-89. PubMed ID: 22191448
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Application of biofilm dispersion-based nanoparticles in cutting off reinfection.
    Li X; Lin S; Wang Y; Chen Y; Zhang W; Shu G; Li H; Xu F; Lin J; Peng G; Fu H
    Appl Microbiol Biotechnol; 2024 Jun; 108(1):386. PubMed ID: 38896257
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The challenges and applications of nanotechnology against bacterial resistance.
    Lei Z; Karim A
    J Vet Pharmacol Ther; 2021 May; 44(3):281-297. PubMed ID: 33277732
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evolution of biofilm-forming pathogenic bacteria in the presence of nanoparticles and antibiotic: adaptation phenomena and cross-resistance.
    Mann R; Holmes A; McNeilly O; Cavaliere R; Sotiriou GA; Rice SA; Gunawan C
    J Nanobiotechnology; 2021 Sep; 19(1):291. PubMed ID: 34579731
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Challenges and solutions in polymer drug delivery for bacterial biofilm treatment: A tissue-by-tissue account.
    Kasza K; Gurnani P; Hardie KR; Cámara M; Alexander C
    Adv Drug Deliv Rev; 2021 Nov; 178():113973. PubMed ID: 34530014
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stopping the Unstoppable: Unconventional Methods to Prevent the Biofilm Growth.
    Jain N; Mansuri A
    Curr Drug Discov Technol; 2020; 17(4):515-522. PubMed ID: 31362660
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibiotic resistance.
    Frieri M; Kumar K; Boutin A
    J Infect Public Health; 2017; 10(4):369-378. PubMed ID: 27616769
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recent Advances in Nanotechnology-Aided Materials in Combating Microbial Resistance and Functioning as Antibiotics Substitutes.
    Munir MU; Ahmed A; Usman M; Salman S
    Int J Nanomedicine; 2020; 15():7329-7358. PubMed ID: 33116477
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Emerging nanotechnology based strategies for diagnosis and therapeutics of urinary tract infections: A review.
    Kumar MS; Das AP
    Adv Colloid Interface Sci; 2017 Nov; 249():53-65. PubMed ID: 28668171
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mesoporous silica nanoparticles as diagnostic and therapeutic tools: how can they combat bacterial infection?
    Şen Karaman D; Manner S; Rosenholm JM
    Ther Deliv; 2018 Mar; 9(4):241-244. PubMed ID: 29495945
    [No Abstract]   [Full Text] [Related]  

  • 53. Novel Strategies to Combat Bacterial Biofilms.
    Hemmati F; Rezaee MA; Ebrahimzadeh S; Yousefi L; Nouri R; Kafil HS; Gholizadeh P
    Mol Biotechnol; 2021 Jul; 63(7):569-586. PubMed ID: 33914260
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tolerant Small-colony Variants Form Prior to Resistance Within a Staphylococcus aureus Biofilm Based on Antibiotic Selective Pressure.
    Manasherob R; Mooney JA; Lowenberg DW; Bollyky PL; Amanatullah DF
    Clin Orthop Relat Res; 2021 Jul; 479(7):1471-1481. PubMed ID: 33835090
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Virulence-targeted Antibacterials: Concept, Promise, and Susceptibility to Resistance Mechanisms.
    Ruer S; Pinotsis N; Steadman D; Waksman G; Remaut H
    Chem Biol Drug Des; 2015 Oct; 86(4):379-99. PubMed ID: 25589217
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quorum Sensing Inhibition by Marine Bacteria.
    Borges A; Simões M
    Mar Drugs; 2019 Jul; 17(7):. PubMed ID: 31340463
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New antibiotic agents and approaches to treat biofilm-associated infections.
    Lynch AS; Abbanat D
    Expert Opin Ther Pat; 2010 Oct; 20(10):1373-87. PubMed ID: 20636186
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A multifaceted 'omics' approach for addressing the challenge of antimicrobial resistance.
    Cohen A; Bont L; Engelhard D; Moore E; Fernández D; Kreisberg-Greenblatt R; Oved K; Eden E; Hays JP
    Future Microbiol; 2015; 10(3):365-76. PubMed ID: 25812460
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metal nanobullets for multidrug resistant bacteria and biofilms.
    Chen CW; Hsu CY; Lai SM; Syu WJ; Wang TY; Lai PS
    Adv Drug Deliv Rev; 2014 Nov; 78():88-104. PubMed ID: 25138828
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Agents that inhibit bacterial biofilm formation.
    Rabin N; Zheng Y; Opoku-Temeng C; Du Y; Bonsu E; Sintim HO
    Future Med Chem; 2015; 7(5):647-71. PubMed ID: 25921403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.